Verapamil Study | Peyronie's Disease

v

Peyronie's Disease and Topical Verapamil Study

METHOD
645 Patients

Verapamil gel 40 mg twice daily


Evaluated for:
Change in curvature
Plaque decrease
Erection quality
Relief of pain
Side effects

RESULTS
Change in curvature 66.8%
Plaque decrease 85%
Erection quality improved 91.2%
Relief of pain 96.3%
Contact dermatitis 0.8%

RESULTS
113 Patients Treated >6 months

Change in curvature 69.4%
Plaque decrease 89.1%
Erection quality improved 92.1%
Relief of pain 95.8%

Ver Plac

N=33 N=14 p-value
Curvature 84.8% 35.7% >0.05
Plaque 100% 50.0% >0.05
Pain 92.3% 71.4% n.s.
Erection 84.0% 33.3% >0.05